title: [Key points for the treatment of the elderly with bipolar disorder].
abstract: BACKGROUND
  There is a lack of research into the treatment of the elderly with bipolar disorder. The Dutch guidelines for the treatment of older persons with bipolar disorder are based primarily on research relating to younger adults.
  
  
  OBJECTIVE
  To define key points for the treatment of bipolar disorder in later life.
  
  
  METHODS
  The working group on the elderly of the Dutch Foundation for Bipolar Disorder defined key points in several consensus meetings based on clinical experience and research literature.
  
  
  RESULTS
  Recommendations were drawn up for the treatment of the elderly with bipolar disorder relating to somatic comorbidity, pharmacotherapy, cognitive dysfunctions and psychosocial support.
  
  
  CONCLUSIONS
  In general the Dutch Guidelines for the treatment of Bipolar Disorder are applicable for the elderly, provided the key points are taken into consideration.
authors.affiliation: a.dols@ggzingeest.nl
authors.forename: A
authors.initials: A
authors.lastname: Dols
authors.forename: H
authors.initials: H
authors.lastname: van Gerven
authors.forename: F
authors.initials: F
authors.lastname: Oostervink
authors.forename: S
authors.initials: S
authors.lastname: Schouws
authors.forename: I
authors.initials: I
authors.lastname: Tolner
authors.forename: R W
authors.initials: RW
authors.lastname: Kupka
authors.forename: M L
authors.initials: ML
authors.lastname: Stek
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000523:psychology*; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy / Q000628:therapy*; D004565:Electroconvulsive Therapy; D006801:Humans; D018020:Lithium Compounds / Q000009:adverse effects / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011613:Psychotherapy; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D001569:Benzodiazepines